The effort required under this PWS is to provide non-personal support services to namru-SA. Performance will include intramural research and development support services for four scientific…
Active Awarded
- Contract number
- N0018926FB033
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Naval Supply Systems Command
Department of the Navy, Department of Defense
- Obligated
- $2,437,411
Award facts
- Contract value 16% obligated
-
- $8,476,964.04 Current, with exercised options
- $14,964,751.65 Potential, with all options
- Completion date 19% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Bureau of Medicine and Surgery Department of the Navy, Department of Defense
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Reston, VA 20190, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of the Navy Bureau of Medicine and Surgery issued a delivery order to Leidos, Inc. on June 23, 2026, with a ceiling value of $14,964,751.65, under the Omnibus IV Military Medical Research and Development IDIQ for non-personal support services to the Naval Medical Research Unit San Antonio (NAMRU-SA).
Omnibus IV is an indefinite delivery contract supporting intramural research and development across federal medical research organizations. The order funds performance at NAMRU-SA's Reston, VA facility and runs through April 1, 2028. Work includes R&D support services for four scientific directorates and their respective departments, priced on a cost-plus-fixed-fee basis. No set-aside was used for this award.
Description
The effort required under this PWS is to provide non-personal support services to namru-SA. Performance will include intramural research and development support services for four scientific directorates and their respective departments.
Quick answers
Who was awarded contract N0018926FB033?
N0018926FB033 was awarded to Leidos, Inc. by Naval Supply Systems Command (Department of the Navy) on June 23, 2026.
How much is contract N0018926FB033 worth?
The government has obligated $2,437,411 on N0018926FB033. Its current value, with exercised options, is $8,476,964. Its potential value, with all options, is $14,964,752.
Which agency awarded contract N0018926FB033?
Naval Supply Systems Command (Department of the Navy) awarded N0018926FB033, with funding from Bureau of Medicine and Surgery (Department of the Navy).
Is contract N0018926FB033 an order under another contract?
Yes. N0018926FB033 is a delivery order under HT001122D0028, an indefinite delivery contract, on Omnibus IV Military Medical Research And Development (OMNIBUS IV).
Was contract N0018926FB033 competed?
The extent of competition for N0018926FB033 was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award